Skip to main content

The need to increase antimicrobial resistance surveillance among forcibly displaced persons (FDPs)


Antimicrobial resistance (AMR) poses a significant threat to human health as 4.95 million deaths were associated with bacterial AMR in 2019 and is projected to reach 10 million by 2050. To mitigate AMR, surveillance is an essential tool for determining the burden of AMR and providing the necessary information for its control. However, the global AMR surveillance is inadequate and particularly limited among forcibly displaced persons (FDPs) despite having higher risks of harboring these pathogens. Predisposing factors among this group include poor living conditions, limited access to treatment and diagnostic tests, and inadequate trained health professionals in refugee camps. Strengthening AMR surveillance among FDPs would address the identified gaps and facilitate formulation and implementation of evidence-based policies on AMR control and prevention response. This article provides information on the growing population of FDPs, factors contributing to the AMR burden and AMR surveillance gaps in FDPs and highlighted recommendations for control.

Definition of terms


The threat of antimicrobial resistance (AMR) remains alarming, as 4.95 million deaths were associated with bacterial AMR in 2019 [3]. This indicates that there is a risk of attaining the predicted annual 10 million AMR-related deaths before 2050 [4]. Intensifying efforts includes improving rapid diagnostics of infectious diseases, discovering new antibiotics & vaccines, enforcing regulations on antimicrobial stewardship and ultimately improving AMR surveillance globally [5]. Although there has been an increase in AMR surveillance in the general population over the past decade, even though not sufficient, surveillance has been particularly limited among a key population group—forcibly displaced persons (FDPs)— whose conditions predispose them to AMR [6, 7]. Recent epidemics and pandemics, such as Ebola, COVID-19, and Middle East Respiratory Syndrome (MERS), have shown that migration contribute to the spread of infectious diseases including AMR [8]. Considering that the living conditions of FDPs—poor sanitation, inadequate water supply, overcrowding, and malnutrition—provide an optimal environment for the incubation of AMR, their chance of being exposed to AMR is higher than the voluntary travelers [9]. A study on AMR amongst European migrants revealed that people subjected to forced migration and the exclusionary living conditions that often ensue had a higher prevalence of carriage or infection with AMR than other migrant groups [10]. This necessitates the need to prioritize AMR surveillance among this population to identify the right strategies to mitigate AMR burden in this group. In this article, we provide information on the growing population of FDPs, factors contributing to the AMR burden in this group, AMR surveillance gaps and recommendations to address these issues.

Growing population of FDPs

According to the United Nations High Commissioner for Refugees (UNHCR), the number of FDPs is estimated at 90 million globally—the highest since World War II—propelled by the rising persecution, conflict, violence, human rights violations and other events actively disturbing public order, such as natural disasters. Internally-displaced people, refugees and asylum seekers account for about 57%, 29%, and 5% of the FDP population, respectively [2]. 83% of refugees and asylum seekers are hosted in low and middle-income countries, where disease surveillance is generally weak [2]. Estimations from Russian/Ukraine war revealed that around 12.8 million people have been displaced in Ukraine so far, majority of who have not left the country (internally displaced) [11] ( Recent estimation shows that about 7.7 million people are internally displaced as a result of the conflict. Also, in Africa, an upward trend of forced displacement has been observed with over 32 million Africans displaced over the past decade largely due to repression of government against citizens, and extremist group violence (

Factors contributing to the burden of AMR among FDPs

Endemicity of AMR in FDPs’ country of origin

A significant factor contributing to AMR burden among forced migrants is the baseline endemicity of AMR in the countries of origin [12]. Although Antimicrobial Stewardship Programs (ASPs) have been widely engaged in many High-Income Countries (HICs), the extensive adoption of hospital-based ASPs in Low- and Middle- Income Countries (LMICs) has not been accomplished [13]. This poor implementation of ASPs in LMICs has also affected countries like Syria, Venezuela, Afghanistan, South Sudan, and Myanmar where majority (69%) of refugees originate from hence, fostering their predisposition to AMR [2, 14]. For instance, studies conducted in two major Syrian cities, Aleppo and Damascus, found that over 85% of antibiotics were sold without prescription, and similar practice is seen across the Middle East, where the prevalence rate of antibiotic self-medication ranges from 19–82% [15, 16]. Due to issues facing ASPs in LMICs, it is unsurprising that 60% of wounded Syrian refugees in Germany screened for AMR harbored gram-negative Multidrug Resistance (MDR) pathogens [17].

Unfavorable climate conditions

Issues of flood arising on account of climate change in many LMICs especially countries with the most refugees also predispose them to AMR. Climate change fosters the spread of AMR as climate warming increases the capacity of the atmosphere to hold water leading to several disasters including flooding [18]. This has the ability of contaminating domestic water with sewage containing AMR [18], hence the risk of acquiring AMR among FDPs. In addition to this, climate change across this region also results in increase in the atmospheric temperature thereby resulting in heat which favors the spread of AMR [19].

Poor living conditions of migrants

Inadequate living conditions of migrants, such as inadequate living space, unavailability of safe water and adequate sanitation facilities, and poor access to healthcare and comprehensive case management also favors the spread of AMR [12]. For instance, the immigrant housing overcrowding rate was discovered to be 17% in the Organization for Economic Co-operation and Development (OECD) and the European Union (EU), against 8% and 11% among the native-born, respectively and about 30% of immigrants live in relative poverty in both the OECD and the EU (,key%20factor%20in%20well%2Dbeing). Also, limited international data available on undocumented immigrants suggest they are extremely vulnerable to lower self-reported health, accidents, injuries, psychosocial distress and unsafe water [20]. For instance, the United Nations High Commissioner for Refugees (UNHCR) ascertained that majority of refugee camps are yet to meet the international water accessibility limit (the accessibility of physically available, safe, acceptable and affordable water whose source must be within 1000 m from home and collection time must not exceed 30 min [21]), and several studies have shown water to be a major environmental reservoir of infectious diseases including AMR. Studies conducted by Hayward et al. have shown that many wastewaters which eventually find their way into water bodies contain AMR [22]. Poor infrastructure for wastewater treatment and deliberate contamination of water sources in refugees’ country of origin and camps have increased their susceptibility to AMR. Studies carried out Alhaj and Kassem revealed that poor wastewater infrastructure in Lebanon camp for Syria refugees resulted in the detection of mcr-1 in Proteus mirabilis (a gene that can confer resistance to colistin) in domestic water in the refugee camp [23]. Among the FDP groups, the refugee appears to have relatively better living conditions due to more attention from international agencies, as this brings about funding and other necessary assistance, compared to IDP camps in which the national government often needs to request for such aid before it is granted [24]. Despite the funding from the international community, many refugees still have unmet health needs [25]. For instance, a study carried out by Suphanchaimat et al. in Thailand revealed the prevalence of unmet needs among urban refugees and asylum seekers (URAS) to be 54.1% 55. Even worse is the health care of asylum seekers as the majority, particularly those without essential documents, cannot access health care due to strict regulation policies and fear of being caught, thereby falling between the cracks of health care providers and organizations providing humanitarian aids [12]. This will likely further exacerbate the health conditions of this group, with the increasing possibility of multiplying the existing AMR genes. Nellums and colleagues further demonstrated that, while transmission of AMR in FDPs’ countries of origin is more predominant due to their vulnerable circumstances, transmission of AMR still occurs during the migration trajectory in transit or the host nations [10]. Other studies [26, 27] further demonstrated this finding with migrants following similar travel paths found to be colonized with the same organism. Another cross-sectional study also showed Methicillin-Resistant Staphylococcus aureus (MRSA) clusters with transmission incidents across four refugee camps in Switzerland with no trace to migrants' origins or migratory trajectory ( This further emphasize that AMR is significantly acquired in the host nations or while in transit, suggesting that AMR transmission occurs between migrants or from the local population to migrants. Hence, it is necessary to investigate and curtail those factors responsible for AMR transmission at each migration phase.

AMR surveillance gaps among FDPs

Although there are significant gaps in AMR surveillance among FDPs globally, AMR surveillance among European refugees still relatively fares better. While there is a need for more studies among European migrants, studies among refugees and Internally Displaced Persons (IDPs) in low-income nations, where the majority of FDPs are hosted, are lacking, resulting in a dearth of data regarding AMR trends among FDPs hosted in low-income countries [28].

AMR surveillance among FDPs in Middle and South East Asia

Generally, AMR surveillance of the populace in the Middle East Asia and Africa, where over 60% of FDPs are hosted, is lacking [2, 28]. For instance, in many region of the South Eastern Asia, implementation of the NAPs on AMR is sub-optimal (poor implementation of NAPs as studies conducted among 10 South East Asia countries by Chua et al. 2021 revealed that only parts of the NAP frameworks and not the whole, were implemented by many of the countries [29]), albeit most countries have developed their NAPs [30]. In addition to this, there is also a paucity of AMR surveillance network specific to Asia [30] and one health approach for synergizing effort on AMR surveillance is also lacking [30].

AMR surveillance among FDPs in sub-Saharan Africa

Also, there is a paucity of studies on AMR among FDPs in sub-Saharan Africa (sSA) and this is majorly due to the absence of regional sub-Sahara African network coupled with paper-based nature of some information systems have made the collection of AMR data very demanding and time consuming [31]. For instance, a study reported that barely 11 (25%) out of 44 sSA countries had National Action Plans (NAPs) on AMR, with just 32% and 2% performing routine AMR surveillance on clinical and veterinary pathogens, respectively [32]. This is an emergency considering the high preponderance of antibiotic misuse and overuse in these regions, ranging from 4.4 to 27.3 daily doses per 1,000 inhabitants [33]. Besides, Owoaje et al. reported that over 80% of physical health symptoms in IDP camps in sSA are due to infectious diseases, predominantly malaria, acute respiratory infection and diarrhea [29]. Considering the background history of antibiotic misuse, poor living conditions of IDPs and refugee camps in this setting, inadequate numbers of trained health professionals and absence of relevant diagnostic tests to confirm the presence of specific diseases, the AMR prevalence is reasonably expected to be significant. Hence, it is unjust to leave out this population as they are more likely to succumb to the devastating effects of AMR pathogens due to the harsh conditions they live in—more than 52% and 24% of children and adults respectively living in IDPs in Africa are malnourished [29]. Weak immunity resulting from malnutrition increases the chances of infections including AMR infection and there is currently paucity of research in this area as only little attention have been given to malnutrition being a facilitator of AMR especially in sSA. A study carried by Ahmed et al. among 402 hospitalized under 5 children suffering from bacteremia in Tanzania shows the point prevalence of bacteremia among malnourished children to be 56/402, with multidrug resistant bacteria being the causative agent [34].

AMR surveillance in Europe

Despite the dearth of AMR surveillance among many regions, there has been a commendable effort in Europe. EARS-Net and CAESAR are major networks involved in AMR surveillance in Europe. The success of these networks in giving detailed data on AMR is due to proper networking across around 30 different European countries and 19 countries in Eastern Europe and central Asia respectively. The detailed networking and effective communication across all the regions involved, coupled with adequate funding have largely contributed to the effectiveness of AMR surveillance in Europe ( Both networks collaboratively provide surveillance data for almost all the 53 Member States in the WHO European Region [28] although AMR surveillance among FDPs is currently lacking. Also, Also, Nellums et al. estimated that about 23 studies on AMR among migrants were conducted between 2006 and 2016 across 7 European countries with the pooled prevalence of any detected AMR carriage or infection among FDPs (33%) higher than that of other migrants (6.6%) [10]. Another WHO community-based study on AMR among Syrian refugees and host communities in Turkey showed refugees had higher Methicillin-Resistant Staphylococcus aureus (MRSA) and Extended Spectrum Beta-Lactamase (ESBL) positivity rates than Turkish citizens (Refugees MRSA & ESBL: 6.7% & 17.9% respectively; Turkish citizens MRSA & ESBL: 3.2% and 14.3% respectively) [7]. These signify the preponderance of AMR among FDPs, compared to the local population. The Global AMR & Use Surveillance System (GLASS), which is the first global collaborative effort to standardize AMR surveillance aimed at providing standardized approach in the collection, analysis, interpretation and sharing of data by countries. The approach seeks to actively support capacity building and monitor the status of existing and new national surveillance systems. However, despite the increased AMR surveillance in Europe, there is need for further improvement. For instance, AMR data that eventually get into GLASS are only those approved by the country, hence the risk of being biased [31].

There is a common limitation among all AMR surveillance gaps among many regions of the world, which is the discrepancies in the stages of development of AMR surveillance systems which in turn has made cross-country comparisons impossible [31]. Hence, adequate comparison cannot be made between the prevalence of AMR in the refugees’ countries of origin and destination countries.

AMR surveillance gap among different regions


Surveillance gaps


• The discrepancies in the stages of development of AMR surveillance systems across different countries have made cross-country comparisons impossible [31]. Hence, cross country AMR data required for curbing data among FDPs are lacking


• AMR data that eventually go into GLASS are only those approved by countries, hence the risk of sample bias as it may not be an accurate representation of the country’s data [31]


• Lack of formal AMR surveillance network specific to Asia Specific Region [30], although several networks collect data on selected pathogens in this region. This region also lacks multi-sectoral and one health approach for synergizing efforts on AMR surveillance [30]


• Lack of regional sub-Sahara African network coupled with paper-based nature of some information systems have made the collection of AMR data very demanding and time consuming [31]

North America

• There is an established comprehensive surveillance system for AMR in United States and Canada. However, there is a need for better coordination and data sharing between different states and provinces. Additionally, surveillance gaps might exist in less populated areas or among certain healthcare facilities with limited resources [35]

South America

• In this region, AMR surveillance systems countries. Countries such as Brazil, Argentina, and Colombia, have made significant progress in establishing surveillance networks and implementing national action plans. However, other countries in the region such as Bolivia, El Salvador, and Honduras face challenges due to limited resources, infrastructure, and coordination among healthcare systems [36]


• There is a robust surveillance system for AMR in Australia through the Australian Group on Antimicrobial Resistance (AGAR). The country has implemented various initiatives to monitor and respond to AMR. In the Pacific region, surveillance capacities vary among individual countries, with some facing resource constraints and limited infrastructure for comprehensive AMR surveillance [36]

Recommendations and conclusion

To address the issues above, the following recommendations are required:

Overall strengthening of AMR surveillance globally especially in low income countries: There is a need for overall strengthening of AMR surveillance globally, particularly in low-income nations. For instance, upper middle- and high-income nations have a central repository for collecting AMR data, such as Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR), the European Antimicrobial Resistance Surveillance Network (EARS-Net), the Latin American Network for Antimicrobial Resistance Surveillance (Rede Latinoamericana de Vigilancia de la Resistencia a los Antimicrobianos [ReLAVRA]), and the Western Pacific Regional Antimicrobial Consumption Surveillance System (WPRACSS) (,key%20factor%20in%20well%2Dbeing). Unfortunately, such regional AMR networks are lacking in sSA, thereby limiting the availability of relevant AMR data from the continent. In order to rectify this issue, there is the need for the creation of central repository for the collection of AMR data, proper coordination of this repository by health experts and other required professionals and so on.

  • Ensuring strong regional network in sub-Saharan African countries

Regional level data on AMR and FDPs is important as this will inform the required strategy and the accurate amount of resources required for curbing the spread of AMR. Data on AMR in FDPs’ region of origin will alert refugee camp coordinators on imposing necessary measures that will curb the spread of AMR. Also, a regional sSA network would bridge data gap on FDPs because it will help in tracking the specific point of acquisition of AMR (whether region of origin or in transit), making accurate data on FDPs available.

  • Incorporation of well spelt-out strategies for curbing AMR into GLASS and NAPs.

It is also worth noting that the WHO Global Actional Plan on AMR and Global AMR & Use Surveillance System (GLASS) do not have specific strategies for conducting AMR surveillance among FDPs, thereby necessitating the revision of these policy documents. Likewise, each country's AMR National Action Plans should clearly articulate the strategies to improve AMR surveillance among refugees and IDPs. Some of these strategies include, increasing AMR surveillance in countries of AMR prevalence, prioritizing AMR surveillance during transit, incorporating AMR surveillance on refugee camps, enforcing measures that prevent the spread of AMR in refugee camp where detected and provision of conducive environment and maximum resources for refugees.

  • Speedy addressing of factors preventing the implementation of NAPs

Also, factors hindering the adequate implementation of NAPs, as elucidated by Kariuki et al., such as lack of political commitment, inadequate funding, and inadequate capacity [37], need to be swiftly addressed by conducting strategic advocacy to the policymakers to increase funding for AMR surveillance. Another key step in the right direction is determining the baseline AMR of displaced people and AMR level in transit and while in the host nations. This would perhaps help understand the full picture of AMR transmission dynamics among migrants, as each migration stage has its peculiarities and might require different measures to curtail the transmission of AMR. Of recent, the German government authorized MDR organism screening of refugees upon admission to healthcare facilities [38]. However, this practice should be recommended at the early stage of registering refugees in order to know the baseline endemicity of AMR among displaced people. Also, as evidence has shown that living conditions of the IDP and refugee camps provide optimal conditions for AMR to thrive, a robust surveillance system would help in identifying which areas contribute the most to the AMR burden, leading to advocacy to policymakers to prioritize addressing those areas, as resources are finite. Ultimately, there would be a need to improve the overall living conditions of FDPs by providing adequate water supply, proper sanitation, and good hygiene to deter AMR incubation and also allow FDPs, particularly asylum seekers, to access good health care regardless of their status as it is their human rights.

Total regulation of antimicrobial stewardship

Total ban on unethical administration of antimicrobials will go a long a way in curbing the burden of AMR. This involve enforcing policies that allow only certified personnels to administer antimicrobials. Also, more sensitizations on the risk of antimicrobials should be carried out especially in sub-Sahara Africa countries where unethical administration and use of antimicrobials is more common.

Availability of data and materials

Not applicable.



Antimicrobial resistance


Multidrug resistance


Middle East Respiratory Syndrome


United Nations High Commissioner for Refugees


Methicillin-Resistant Staphylococcus aureus


Extended Spectrum Betalactamase


Sub-Sahara Africa


Antimicrobial Stewardship Programs


Low- and Middle- Income Countries


  1. Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 2018;4(3):482–501. (PMID: 31294229; PMCID: PMC6604941).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. The UNHCR Global Trends Forced Displacement in 2021 (Accessed: 13 Aug 2022)

  3. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55.

    Article  CAS  Google Scholar 

  4. O'Neill J. Review on antimicrobial resistance antimicrobial resistance: tackling a crisis for the health and wealth of nations. London: Review on Antimicrobial Resistance; 2014. Available from:

  5. Majumder MAA, Rahman S, Cohall D, Bharatha A, Singh K, Haque M, Gittens-St HM. Antimicrobial stewardship: fighting antimicrobial resistance and protecting global public health. Infect Drug Resist. 2020;13:4713–38. (PMID: 33402841; PMCID: PMC7778387).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Countries step up to tackle antimicrobial resistance (Accessed: 12/08/2022)

  7. Community-based antimicrobial resistance screening among Syrian refugees and the host community in Turkey. Copenhagen: WHO Regional Office for Europe; 2021. Licence: CC BY-NCSA3.0 IGO.

  8. Desai AN, Mohareb AM, Hauser N, Abbara A. Antimicrobial resistance and human mobility. Infect Drug Resist. 2022;15:127–33. (PMID: 35046676; PMCID: PMC8763254).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bokhary H, Pangesti KNA, Rashid H, Abd El Ghany M, Hill-Cawthorne GA. Travel-related antimicrobial resistance: a systematic review. Trop Med Infect Dis. 2021;6(1):11. PMID: 33467065; PMCID: PMC7838817.

  10. Nellums LB, Thompson H, Holmes A, Castro-Sánchez E, Otter JA, Norredam M, et al. Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18:796–811.

    Article  PubMed  PubMed Central  Google Scholar 

  11. (Accessed: 8 Dec 2022)

  12. Abd El Ghany, M., Fouz, N., Hill-Cawthorne, G.A. Human movement and transmission of antimicrobial-resistant bacteria. In: Manaia, C., Donner, E., Vaz-Moreira, I., Hong, P. (eds) 2020.

  13. de Oliveira TC, Rodrigues PT, Menezes MJ, Goncalves-Lopes RM, Bastos MS, Lima NF, et al. Genome-wide diversity and differentiation in New World populations of the human malaria parasite Plasmodium vivax. PLoS Negl Trop Dis. 2017;11(7): e0005824.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Antimicrobial resistance (Accessed: 13 Aug 2022)

  15. Jakovljevic M, Al ahdab S, Jurisevic M, and Mouselli S. Antibiotic resistance in Syria: a local problem turns into a global threat. Front. Public Health. 2018;6:212.

  16. Faten Alhomoud, Zainab Aljamea, Reem Almahasnah, Khawlah Alkhalifah, Lama Basalelah, Farah Kais Alhomoud, Self-medication and self-prescription with antibiotics in the Middle East—do they really happen? A systematic review of the prevalence, possible reasons, and outcomes. Int J Infect Dis. 2017;57:3–12. ISSN 1201-9712.

  17. Heudorf U, Albert-Braun S, Hunfeld KP, Birne FU, Schulze J, Strobel K, Petscheleit K, Kempf VA, Brandt C. Multidrug-resistant organisms in refugees: prevalences and impact on infection control in hospitals. GMS Hyg Infect Control. 2016;11:Doc16. PMID: 27579250; PMCID: PMC4987489.

  18. Burnham JP. Climate change and antibiotic resistance: a deadly combination. Ther Adv Infect Dis. 2021;8:2049936121991374. (PMID: 33643652; PMCID: PMC7890742).

    Article  PubMed  PubMed Central  Google Scholar 

  19. Pietikäinen J, Pettersson M, Bååth E. Comparison of temperature effects on soil respiration and bacterial and fungal growth rates. FEMS Microbiol Ecol. 2005;52:49–58.

    Article  PubMed  Google Scholar 

  20. Sousa E, Agudelo-Suárez A, Benavides FG, Schenker M, Garcia AM, Benach J, Declos C. ITSAL project: Immigration, work and health in Spain: the influence of legal status and employment contract on reported health indicators. Int J Publ Health. 2010;55(5):443–51.

    Article  Google Scholar 

  21. Hayward C, Ross KE, Brown MH, Whiley H. Water as a source of antimicrobial resistance and healthcare-associated infections. Pathogens. 2020;9(8):667. (PMID: 32824770; PMCID: PMC7459458).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Alhaj Sulaiman AA, Kassem II. First report of the plasmid-borne colistin resistance gene (mcr-1) in Proteus mirabilis isolated from domestic and sewer waters in Syrian refugee camps. Travel Med Infect Dis. 2020;33:101482.

  23. Mooney E. The concept of internal displacement and the case for internally displaced persons as a category of concern. Refug Surv Q. 2005;24:9–26.

    Article  Google Scholar 

  24. Suphanchaimat R, Sinam P, Phaiyarom M, et al. A cross sectional study of unmet need for health services amongst urban refugees and asylum seekers in Thailand in comparison with Thai population, 2019. Int J Equity Health. 2020;19:205.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Angeletti S, Ceccarelli G, Vita S, et al. Unusual microorganisms and antimicrobial resistances in a group of Syrian migrants: sentinel surveillance data from an asylum seekers centre in Italy. Travel Med Infect Dis. 2016;14:115–22.

    Article  PubMed  Google Scholar 

  26. Georgakopoulou T, Mandilara G, Mellou K, et al. Resistant shigella strains in refugees, August–October 2015 Greece. Epidemiol Infect. 2016;144:2415–9.

    Article  CAS  PubMed  Google Scholar 

  27. Piso RJ, Kach R, Pop R, et al. A cross-sectional study of colonization rates with methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) and carbapenemase-producing Enterobacteriaceae in four Swiss refugee centres. PLoS ONE. 2017;12: e0170251.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Iskandar K, Molinier L, Hallit S, et al. surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture. Antimicrob Resist Infect Control. 2021;10:63.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Alvin Qijia Chua. Monica Verma, Li Yang Hsu, Helena Legido-Quigley. An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approach. 2021.

    Article  Google Scholar 

  30. Ahmed M, Mirambo MM, Mushi MF, Hokororo A, Mshana SE. Bacteremia caused by multidrug-resistant bacteria among hospitalized malnourished children in Mwanza, Tanzania: a cross sectional study. BMC Res Notes. 2017;10(1):62. (PMID: 28122629; PMCID: PMC5267369).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Owoaje ET, Uchendu OC, Ajayi TO, Cadmus EO. A review of the health problems of the internally displaced persons in Africa. Niger Postgrad Med J. 2016;23:161–71.

    Article  PubMed  Google Scholar 

  32. (Accessed: 8 Dec 2022).

  33. Chua AQ, Verma M, Hsu LY, Legido-Quigley H. An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approach. Lancet Reg Health-Western Pac. 2021;7: 100084.

    Article  Google Scholar 

  34. WHO Report on Surveillance of Antibiotic Consumption (Accessed: 8 Dec 2022).

  35. Otto SJG, Haworth-Brockman M, Miazga-Rodriguez M, Wierzbowski A, Saxinger LM. Integrated surveillance of antimicrobial resistance and antimicrobial use: evaluation of the status in Canada (2014–2019). Can J Public Health. 2022;113(1):11–22.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Iskandar K, Molinier L, Hallit S, Sartelli M, Hardcastle TC, Haque M, Lugova H, Dhingra S, Sharma P, Islam S, Mohammed I. Surveillance of antimicrobial resistance in low-and middle-income countries: a scattered picture. Antimicrob Resist Infect Control. 2021;10(1):1–9.

    Article  Google Scholar 

  37. Kariuki S, Kering K, Wairimu C, Onsare R, Mbae C. Antimicrobial resistance rates and surveillance in Sub-Saharan Africa: where are we now? Infect Drug Resist. 2022;15:3589–609.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Häsler R, Kautz C, Rehm an A, Podschun R, Gassling V, Brzoska P, Sherlock J, Gräsner JT, Hoppenstedt G, Schubert S, Ferlinz A, Lieb W, Laudes M, Heinsen FA, Scholz J, Harmsen D, Franke A, Eisend S, Kunze T, Fickenscher H, Ott S, Rosenstiel P, Schreiber S. The antibiotic resistome and microbiota landscape of refugees from Syria, Iraq and Afghanistan in Germany. Microbiome. 2018;6(1):37. (PMID: 29458422; PMCID: PMC5819293).

    Article  PubMed  PubMed Central  Google Scholar 

Download references




Authors have received no funding.

Author information

Authors and Affiliations



S.I.Y, Y.A.T, H.J.O, and O.V.B. conceptualized the topic, conducted literature review; and drafted the manuscript; O.T.P and A.F.A. drafted the recommendation and revised the manuscript; M.D.O and I.O.O drafted the abstract and revised the final version of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Matifan Dereje Olana.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yusuff, S.I., Tajudeen, Y.A., Oladunjoye, I.O. et al. The need to increase antimicrobial resistance surveillance among forcibly displaced persons (FDPs). Trop Dis Travel Med Vaccines 9, 12 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Antimicrobial resistance
  • Antimicrobial resistance surveillance
  • Forcibly displace persons
  • Drug resistant pathogens